Seasonal malaria chemoprevention (SMC) consists of the intermittent administration of antimalarials to children 3–59 months in areas where transmission is seasonal. Between 2021 and 2022, Malaria Consortium conducted several multi-component SMC implementation studies to build the evidence base around SMC’s suitability in new geographies in East and southern Africa. The qualitative component centred on the acceptability and feasibility of SMC implementation, providing insightful information about the health-seeking behaviours and beliefs surrounding malaria in those contexts. This poster was presented at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: Mozambique | South Sudan | Uganda
Keywords: ASTMH | Capacity development | Community delivery | Data-informed decision-making | Research | SMC
« Back to Publications